{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T19:54:27Z","timestamp":1767210867764},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.numecd.2004.04.002","type":"journal-article","created":{"date-parts":[[2005,4,15]],"date-time":"2005-04-15T11:25:02Z","timestamp":1113564302000},"page":"140-147","source":"Crossref","is-referenced-by-count":30,"title":["Is homocysteine important as risk factor for coronary heart disease?"],"prefix":"10.1016","volume":"15","author":[{"given":"Maurizio","family":"Cesari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Paolo","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Sticchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achille C.","family":"Pessina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2004.04.002_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/aje\/152.2.140","article-title":"Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey","volume":"152","author":"Morris","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.numecd.2004.04.002_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev.nu.12.070192.001431","article-title":"Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease","volume":"12","author":"Kang","year":"1992","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.numecd.2004.04.002_bib3","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","article-title":"Homocysteine and atherothrombosis","volume":"338","author":"Welch","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2004.04.002_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0021-9150(03)00090-X","article-title":"Oral and transdermal estrogens both lower plasma total homocysteine in male-to-female transsexuals","volume":"168","author":"Giltay","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2004.04.002_bib5","first-page":"1526","volume":"274","author":"Nygard","year":"1995","journal-title":"Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study, JAMA"},{"key":"10.1016\/j.numecd.2004.04.002_bib6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM198509193131201","article-title":"Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease","volume":"313","author":"Boers","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2004.04.002_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.numecd.2004.04.002_bib8","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1161\/01.CIR.98.23.2520","article-title":"Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis","volume":"98","author":"Brattstrom","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2004.04.002_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0009-9120(96)00172-5","article-title":"Clinical chemistry and molecular biology of homocysteine metabolism: an update","volume":"30","author":"Miner","year":"1997","journal-title":"Clin Biochem"},{"key":"10.1016\/j.numecd.2004.04.002_bib10","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/01.CIR.95.8.2032","article-title":"Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease","volume":"95","author":"Morita","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2004.04.002_bib11","first-page":"2738","article-title":"Methylenetetrahydrofolate reductase (MTHFR) mutation, homocyst(e)ine, and coronary artery disease","volume":"96","author":"Wilcken","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2004.04.002_bib12","first-page":"262","article-title":"Elevated total plasma homocysteine and 677C\u2192T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease","volume":"59","author":"de Franchis","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.numecd.2004.04.002_bib13","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1182\/blood.V91.11.4158","article-title":"Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction","volume":"91","author":"Girelli","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.numecd.2004.04.002_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/01.CIR.93.1.7","article-title":"Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations","volume":"93","author":"Jacques","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2004.04.002_bib15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/01.ATV.17.3.569","article-title":"Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease","volume":"17","author":"Christensen","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2004.04.002_bib16","first-page":"1","author":"American Heart Association","year":"2000","journal-title":"Heart and Stroke Statistical Update"},{"key":"10.1016\/j.numecd.2004.04.002_bib17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM198509193131210","article-title":"Vascular disease and homocysteine metabolism","volume":"313","author":"Mudd","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2004.04.002_bib18","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI112442","article-title":"Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine","volume":"77","author":"Starkebaum","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2004.04.002_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/JCI118776","article-title":"The oxidant stress of hyperhomocyst(e)inemia","volume":"98","author":"Loscalzo","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2004.04.002_bib20","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/01.CIR.0000085067.55901.89","article-title":"Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine","volume":"108","author":"Stuhlinger","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2004.04.002_bib21","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.ATV.0000035404.18281.37","article-title":"Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: role of chemokine and adhesion molecules","volume":"22","author":"Wang","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2004.04.002_bib22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.ATV.0000014221.30108.08","article-title":"Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion","volume":"22","author":"Silverman","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2004.04.002_bib23","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0735-1097(01)01492-9","article-title":"Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension","volume":"38","author":"Virdis","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2004.04.002_bib24","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1161\/01.CIR.95.5.1119","article-title":"Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans","volume":"95","author":"Tawakol","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2004.04.002_bib25","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.268.7.877","article-title":"A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians","volume":"268","author":"Stampfer","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2004.04.002_bib26","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.CIR.0000014447.06099.FB","article-title":"Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events","volume":"105","author":"Ridker","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2004.04.002_bib27","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1001\/archinte.162.12.1374","article-title":"Plasma total homocysteine and hospitalizations for cardiovascular disease: the Hordaland Homocysteine Study","volume":"162","author":"Nurk","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.numecd.2004.04.002_bib28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/07853890310008206","article-title":"Total plasma homocysteine and restenosis after percutaneous coronary angioplasty: current evidence","volume":"35","author":"Schnyder","year":"2003","journal-title":"Ann Med"},{"key":"10.1016\/j.numecd.2004.04.002_bib29","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM199707243370403","article-title":"Plasma homocysteine levels and mortality in patients with coronary artery disease","volume":"337","author":"Nygard","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2004.04.002_bib30","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.274.13.1049","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2004.04.002_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0167-5273(97)00099-5","article-title":"Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease","volume":"60","author":"Montalescot","year":"1997","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.numecd.2004.04.002_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.med.49.1.31","article-title":"Homocysteine and cardiovascular disease","volume":"49","author":"Refsum","year":"1998","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.numecd.2004.04.002_bib33","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.ATV.17.5.989","article-title":"Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis","volume":"17","author":"Verhoef","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2004.04.002_bib34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/ije\/31.1.59","article-title":"Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies","volume":"31","author":"Ford","year":"2002","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.numecd.2004.04.002_bib35","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","author":"Homocysteine Studies Collaboration","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2004.04.002_bib36","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1161\/01.ATV.17.10.1947","article-title":"Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial","volume":"17","author":"Evans","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2004.04.002_bib37","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.CIR.98.3.204","article-title":"Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study","volume":"98","author":"Folsom","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2004.04.002_bib38","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0002-9149(96)00874-0","article-title":"Plasma total homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery","volume":"79","author":"Verhoef","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2004.04.002_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0021-9150(94)90078-7","article-title":"Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study","volume":"106","author":"Alfthan","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2004.04.002_bib40","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1056\/NEJM199905133401901","article-title":"The effect of folic acid fortification on plasma folate and total homocysteine concentrations","volume":"340","author":"Jacques","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2004.04.002_bib41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0002-9149(01)02286-X","article-title":"Relation of homocysteine, vitamin B(12), and folate to coronary in-stent restenosis","volume":"89","author":"Genser","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2004.04.002_bib42","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1067\/mhj.2000.107546","article-title":"Homocysteine, lipoprotein(a), and restenosis after percutaneous transluminal coronary angioplasty: a prospective study","volume":"140","author":"Miner","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.numecd.2004.04.002_bib43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0021-9150(02)00373-8","article-title":"Coronary heart disease mortality, plasma homocysteine, and B-vitamins: a prospective study","volume":"166","author":"de Bree","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2004.04.002_bib44","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0735-1097(03)00485-6","article-title":"Secondary prevention with folic acid: effects on clinical outcomes","volume":"41","author":"Liem","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2004.04.002_bib45","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0002-9149(03)00281-9","article-title":"Effect of homocysteine-lowering therapy on restenosis after percutaneous coronary intervention for narrowings in small coronary arteries","volume":"91","author":"Schnyder","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2004.04.002_bib46","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jama.288.8.973","article-title":"Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial","volume":"288","author":"Schnyder","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2004.04.002_bib47","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/bmj.316.7135.894","article-title":"Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials","volume":"316","author":"Homocysteine Lowering Trialists\u2019 Collaboration","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.numecd.2004.04.002_bib48","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1053\/euhj.2002.3161","article-title":"Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease","volume":"23","author":"Neal","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2004.04.002_bib49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2362.2003.01135.x","article-title":"Homocysteine-lowering treatment with folic acid plus vitamin B6 lowers urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein: further analysis of secondary end-points of a randomized clinical trial","volume":"33","author":"Vermeulen","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.numecd.2004.04.002_bib50","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1124\/jpet.102.036715","article-title":"Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects","volume":"303","author":"Stanger","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.numecd.2004.04.002_bib51","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1001\/jama.288.16.2023","article-title":"MTHFR 677C\u2192T polymorphism and risk of coronary heart disease: a meta-analysis","volume":"288","author":"Klerk","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2004.04.002_bib52","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/01.CIR.99.1.178","article-title":"Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association","volume":"99","author":"Malinow","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2004.04.002_bib53","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0735-1097(02)03012-7","article-title":"The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study","volume":"41","author":"Rossi","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2004.04.002_bib54","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/ajcn\/63.2.220","article-title":"Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status","volume":"63","author":"Cravo","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.numecd.2004.04.002_bib55","first-page":"230","article-title":"Plasma homocysteine in renal failure","volume":"40","author":"Hultberg","year":"1993","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.numecd.2004.04.002_bib56","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nm0496-386","article-title":"Homocysteine and vascular disease","volume":"2","author":"McCully","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.numecd.2004.04.002_bib57","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1210\/jc.85.3.1049","article-title":"Plasma total homocysteine levels during short-term iatrogenic hypothyroidism","volume":"85","author":"Lien","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2004.04.002_bib58","first-page":"828","article-title":"Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate","volume":"51","author":"Refsum","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.numecd.2004.04.002_bib59","first-page":"2125","article-title":"Changes in folate status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients","volume":"4","author":"Geisler","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.numecd.2004.04.002_bib60","first-page":"473","article-title":"Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy","volume":"114","author":"Ueland","year":"1989","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.numecd.2004.04.002_bib61","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0009-9120(97)00116-1","article-title":"Homocyst(e)ine levels in patients on phenytoin therapy","volume":"30","author":"James","year":"1997","journal-title":"Clin Biochem"},{"key":"10.1016\/j.numecd.2004.04.002_bib62","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1172\/JCI118763","article-title":"The effect of a subnormal vitamin B-6 status on homocysteine metabolism","volume":"98","author":"Ubbink","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2004.04.002_bib63","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/rheumatology\/keg293","article-title":"Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy","volume":"42","author":"Martinez-Taboada","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl. 5","key":"10.1016\/j.numecd.2004.04.002_bib64","doi-asserted-by":"crossref","first-page":"v71","DOI":"10.1093\/ndt\/gfg1053","article-title":"Obesity and hyperhomocysteinaemia after kidney transplantation","volume":"18","author":"Teplan","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.numecd.2004.04.002_bib65","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00007890-199602150-00034","article-title":"Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients","volume":"61","author":"Arnadottir","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.numecd.2004.04.002_bib66","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1570-9639(03)00048-7","article-title":"Structural insights into mutations of cystathionine beta-synthase","volume":"1647","author":"Meier","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.numecd.2004.04.002_bib67","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/hmg\/4.4.623","article-title":"Hyperhomocysteinemia in premature arterial disease: examination of cystathionine beta-synthase alleles at the molecular level","volume":"4","author":"Kozich","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.numecd.2004.04.002_bib68","first-page":"546","article-title":"Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations","volume":"48","author":"Kang","year":"1991","journal-title":"Am J Hum Genet"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475305000323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475305000323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T22:15:19Z","timestamp":1586211319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475305000323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0939475305000323"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2004.04.002","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}